Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.18248 | 7 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.15612 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.16344 | 7 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.11347 | 7 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.13244 | 8 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.28841 | 10 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.74443 | 31 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.13791 | 7 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.1316 | 7 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.15001 | 7 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.13458 | 7 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.13524 | 7 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.15572 | 7 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.1458 | 7 |